KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Biogen (BIIB) EBIT Margin (2016 - 2025)

Historic EBIT Margin for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to 24.19%.

  • Biogen's EBIT Margin fell 123000.0% to 24.19% in Q4 2025 from the same period last year, while for Dec 2025 it was 8.57%, marking a year-over-year decrease of 43900.0%. This contributed to the annual value of 8.57% for FY2025, which is 43900.0% down from last year.
  • Biogen's EBIT Margin amounted to 24.19% in Q4 2025, which was down 123000.0% from 4.62% recorded in Q3 2025.
  • Over the past 5 years, Biogen's EBIT Margin peaked at 36.15% during Q1 2021, and registered a low of 31.65% during Q3 2023.
  • Its 5-year average for EBIT Margin is 4.62%, with a median of 3.0% in 2023.
  • Per our database at Business Quant, Biogen's EBIT Margin soared by 330700bps in 2021 and then crashed by -675900bps in 2023.
  • Over the past 5 years, Biogen's EBIT Margin (Quarter) stood at 21.48% in 2021, then crashed by -94bps to 1.29% in 2022, then tumbled by -1159bps to 13.69% in 2023, then increased by 13bps to 11.9% in 2024, then tumbled by -103bps to 24.19% in 2025.
  • Its EBIT Margin stands at 24.19% for Q4 2025, versus 4.62% for Q3 2025 and 5.25% for Q2 2025.